Naloxone shortage

FDA contracts Canadian company Sabex to supply morphine antagonist pending shortage resolution. Narcan manufacturer Endo had experienced manufacturing difficulties due to DuPont plant shutdown (1"The Pink Sheet" March 26, In Brief). According to the American Society of Health-System Pharmacists, Endo plans to release back orders by early June, while Abbott expects releases in April and May. Sabex' naloxone will not be available for intrathecal use